Yes, BIRAC conducts roadshows and Intellectual Property workshops to sensitize the target audiences about the BIRAC support for the entrepreneurs and relevance of intellectual property. It also provides a platform for the aspiring entrepreneurs to gain knowledge about effective grant writing skills from the experts in the domain.
Snapshot
India - a biotech growth catalyst
India is among the top 12 destinations for biotechnology in the world, with approximately 3% share in the global Biotechnology industry. India is also the leader in the global supply of DPT, BCG and measles vaccines.
The biotechnology industry in India comprises about 600+ core biotechnology companies, approx. 2600+ biotech startups, 41 BIRAC-supported incubators.
India has the second-highest number of US Food & Drug Administration (USFDA)-approved manufacturing plants outside the US. The country is currently home to more than 523 USFDA approved drug manufacturing facilities.
- By 2025, the Indian Biotechnology industry is expected to reach $100 bn
100% FDI is allowed under the automatic route for greenfield pharma.
100% FDI is allowed under the government route for brownfield pharma in upto 74% FDI is under automatic route and beyond 74% is under the government approval route.
FDI up to 100% is allowed under the automatic route for the manufacturing of medical devices.
For further details, please refer FDI Policy
%
Tax deduction on R&D expenditure
%
Annual industrial growth
%
Bio-pharma revenue share
%
Bio-agri revenue share
World's largest producer of recombinant Hepatitis B vaccine
World's largest producer of BT Cotton
World's second highest number of USFDA approved plants
- INDUSTRY SCENARIO
- FOREIGN INVESTMENT
- INDUSTRY TRENDS
- POLICIES & SCHEMES
Industry Scenario
The Indian Biotechnology industry that was valued at $51 bn in 2018, growing at 14.7% year-on-year.
The sector is divided into five major segments- Bio-pharma, Bio-services, Bio-agri, Bio-industrial, and Bio-informatics. The biopharmaceutical sector accounts for the largest share of the biotech industry with a share of 55% of total revenues, followed by bio-agri with 22% market share (2018). Bio-services accounted for 16% of the Biotech industry as India is becoming a leading destination for clinical trials, contract research, and manufacturing activities, which is further fuelling the growth of the bio-services sector, while the remaining market is catered by bio-industrial (8%).
- India currently has 4,50,000+ sq. ft. of incubation space
- 41 bio-incubators have been supported by BIRAC and established since 2014, with more planned across the country
India is also one of the first countries to have a department dedicated to Biotechnology. The Department of Biotechnology has also set up BIRAC (Biotechnology Industry Research Assistance Council). This not-for-profit an interface agency to strengthen and empower emerging biotechnology enterprises to undertake strategic research and innovation.
Growth Drivers
Growing population
India to become the world’s most populous country by 2030
Rising demand for treatments
Increased insurance penetration and a growing burden of disease
Medical infrastructure facilities
$ 200 Bn expenditure planned on medical infrastructure over the next decade
Strong skilled manpower pool
‘National Biopharma Mission’, an Industry-Academia mission to skill the workforce
Cost competitive manufacturing
Development of life-science clusters builds collaborations between research institutes and the private sector
Investible Projects
Investment Opportunities in
- Projects
16
- Opportunity
$1.5 bn
- Promoters
9
- District
13
- Private Projects
0
- Govt. Projects
16
Major Investors
Data On Map
Stakeholders
pin
By: Strategic Investment Research Unit (SIRU)
14 January,03:42 PM
Disclaimer: All views and opinions that may be expressed in the posts on this page as well as post emanating from this page are solely of the individual in his/her personal capacity